Literature DB >> 11820867

Redox refunctionalization of steroid spiroketals. Structure correction of ritterazine M.

Seongmin Lee1, Thomas G LaCour, Douglas Lantrip, Philip L Fuchs.   

Abstract

The structure of the North spiroketal moiety of ritterazine M has been corrected from 1a to 1b. This was accomplished by comparison of published spectra of the natural product with five synthetic spiroketal-alcohols. Synthesis of these models was efficiently accomplished by reductive cleavage of the spiroketal and Sharpless asymmetric dihydroxylation of an isopentyl, methyl 1,1-disubstituted olefin, followed by Suarez iodine[III] oxidative spirocyclization of monoprotected 1 degree,3 degree 1,2 diols.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11820867     DOI: 10.1021/ol0165894

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  5 in total

1.  Preparation of the 5/5-spiroketal of the ritterazines.

Authors:  Douglass F Taber; Jean-Michel Joerger
Journal:  J Org Chem       Date:  2007-03-31       Impact factor: 4.354

Review 2.  Chemistry of trisdecacyclic pyrazine antineoplastics: the cephalostatins and ritterazines.

Authors:  Seongmin Lee; Thomas G LaCour; Philip L Fuchs
Journal:  Chem Rev       Date:  2009-06       Impact factor: 60.622

Review 3.  Chemistry and bioactivities of natural steroidal alkaloids.

Authors:  Mei-Ling Xiang; Bin-Yuan Hu; Zi-Heng Qi; Xiao-Na Wang; Tian-Zhen Xie; Zhao-Jie Wang; Dan-Yu Ma; Qi Zeng; Xiao-Dong Luo
Journal:  Nat Prod Bioprospect       Date:  2022-06-15

4.  Synthesis of C14,15-dihydro-C22,25-epi north unit of cephalostatin 1 via "red-ox" modifications of hecogenin acetate.

Authors:  Seongmin Lee; Daniel Jamieson; Philip L Fuchs
Journal:  Org Lett       Date:  2009-01-01       Impact factor: 6.005

5.  Triple hybrids of steroids, spiroketals, and oligopeptides as new biomolecular chimeras.

Authors:  Abhisek Banerjee; Eduard Sergienko; Stefan Vasile; Vineet Gupta; Kristiina Vuori; Peter Wipf
Journal:  Org Lett       Date:  2009-01-01       Impact factor: 6.005

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.